Mark P. Guerin
2023
In 2023, Mark P. Guerin earned a total compensation of $745.5K as Chief Operating Officer and Chief Financial Officer at Onconova Therapeutics, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $143,853 |
|---|---|
| Option Awards | $50,247 |
| Salary | $500,120 |
| Stock Awards | $18,980 |
| Other | $32,318 |
| Total | $745,518 |
Guerin received $500.1K in salary, accounting for 67% of the total pay in 2023.
Guerin also received $143.9K in bonus, $50.2K in option awards, $19K in stock awards and $32.3K in other compensation.
Rankings
In 2023, Mark P. Guerin's compensation ranked 1,514th out of 2,918 executives tracked by ExecPay. In other words, Guerin earned more than 48.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,514 out of 2,918 | 48th |
Division Manufacturing | 891 out of 1,608 | 45th |
Major group Chemicals And Allied Products | 575 out of 901 | 36th |
Industry group Drugs | 559 out of 864 | 35th |
Industry Pharmaceutical Preparations | 394 out of 622 | 37th |
Source: SEC filing on October 11, 2024.
Guerin's colleagues
We found two more compensation records of executives who worked with Mark P. Guerin at Onconova Therapeutics in 2023.